Zevra Therapeutics ZVRA
NASDAQ ZVRA
$10.18 -0.79 (-7.20%)
At close: Oct 1, 2026 · 4:00 PM EDT

Zevra Therapeutics (ZVRA) Interest Expenses (2014 - 2026)

Updated

Zevra Therapeutics (ZVRA) posted Interest Expenses of $1.71 million for Q1 2026, down 13.1% from $1.97 million a year earlier and down 12.2% from the prior quarter.

Analysis

Zevra Therapeutics (ZVRA) Interest Expenses (2014 - 2026) Analysis & Trends

For FY2025, Zevra Therapeutics' Interest Expenses came in at $7.98 million, up 8.5% from FY2024.

  • Annual Interest Expenses has increased for four consecutive years, with a five-year compound annual growth rate of 10.8% (FY2020 to FY2025).
  • In prior years, Zevra Therapeutics' Interest Expenses was $7.35 million in FY2024 (+389.7%), $1.5 million in FY2023 (+348.1%), $335,000 in FY2022 (+48.2%) and $226,000 in FY2021 (-95.3%).
  • The Q1 2026 figure stands as the lowest quarterly Interest Expenses since Q1 2024.
  • On a year-over-year basis, Interest Expenses has declined in each of the last four quarters, with growth averaging 227.6% over the last eight quarters.
  • The strongest year-over-year quarter for Interest Expenses in the past five years was Q2 2024, with growth of 971.1%; the weakest was Q4 2021, with a decline of 99.6%.
  • According to Business Quant data, Interest Expenses for the three prior quarters was $1.95 million (Q4 2025), $2.05 million (Q3 2025) and $2.01 million (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 281.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -462.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -435.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 673.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 247.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Zevra Therapeutics 650.98 Mn -161.73 Mn 38.18 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 1.71 Mn
Dec 31, 2025 1.95 Mn
Sep 30, 2025 2.05 Mn
Jun 30, 2025 2.01 Mn
Mar 31, 2025 1.97 Mn
Dec 31, 2024 2.19 Mn
Sep 30, 2024 2.31 Mn
Jun 30, 2024 2.11 Mn
Mar 31, 2024 735,000.00
Dec 31, 2023 756,000.00
Sep 30, 2023 366,000.00
Jun 30, 2023 197,000.00
Mar 31, 2023 182,000.00
Dec 31, 2022 170,000.00
Sep 30, 2022 124,000.00
Jun 30, 2022 36,000.00
Mar 31, 2022 5,000.00
Dec 31, 2021 5,000.00
Sep 30, 2021 6,000.00
Jun 30, 2021 16,000.00
API Access

Zevra Therapeutics Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=ZVRA&period=max&api_key=YOUR_API_KEY